<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title>Senomyx Inc. (SNMX) news: Senomyx's CEO Discusses Q1 2014 Results - Earnings Call Transcript - Seeking Alpha</title>
<meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
<meta http-equiv="P3P" content='CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"' />

<script type='text/javascript'>
try {
  window.external.msSiteModeCreateJumplist('SeekingAlpha - Read, Decide, Invest.');
  window.external.msSiteModeAddJumpListItem('Portfolio' ,
  'http://seekingalpha.com/account/portfolio?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('Breaking News - Real-time stock market news updates' ,
  'http://seekingalpha.com/news/all?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('Investment Ideas' ,
  'http://seekingalpha.com/dashboard/investing_ideas?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('Income Investing, Retirement Investing and Dividend Stocks' ,
  'http://seekingalpha.com/dashboard/investing_income?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('ETFs & Portfolio Strategy' ,
  'http://seekingalpha.com/dashboard/etfs?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('Macro View, Market Economy' ,
  'http://seekingalpha.com/dashboard/macro_view?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('My Email Alerts' ,
  'http://seekingalpha.com/account/email_preferences?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
} catch (ex) {
}
</script>
<meta name="application-name" content="Seeking Alpha - Read, Decide, Invest."/>
<meta name="msapplication-TileColor" content="#360000"/>
<meta name="msapplication-TileImage" content="http://static.cdn-seekingalpha.com/images/media_kit/71cdea92-2dc1-419d-8d62-f68b74c1eda8.png"/>
<meta name="msapplication-tooltip" content="Seeking Alpha - Read, Decide, Invest." />
<meta name="msapplication-starturl" content="http://seekingalpha.com?source=ie_task" />
<meta name="msapplication-task" content="name=Portfolio ;action-uri=http://seekingalpha.com/account/portfolio?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=Breaking News - Real-time stock market news updates ;action-uri=http://seekingalpha.com/news/all?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=Investment Ideas ;action-uri=http://seekingalpha.com/dashboard/investing_ideas?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=Income Investing, Retirement Investing and Dividend Stocks ;action-uri=http://seekingalpha.com/dashboard/investing_income?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=ETFs & Portfolio Strategy ;action-uri=http://seekingalpha.com/dashboard/etfs?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=Macro View, Market Economy ;action-uri=http://seekingalpha.com/dashboard/macro_view?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=My Email Alerts ;action-uri=http://seekingalpha.com/account/email_preferences?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<!-- End IE9 Settings -->

<meta property="fb:admins" content="100006791796236" />

<meta name="twitter:card" content="summary">
<meta name="twitter:site" content="@sa_popular">
<meta name="twitter:title" content="Senomyx's CEO Discusses Q1 2014 Results - Earnings Call Transcript">
<meta name="twitter:description" content="Senomyx, Inc. (SNXM) Q1 2014 Earnings Conference Call May 1, 2013 11:00 AM ET 
  Executives
  Gwen Rosenberg - VP, IR and Corporate Communications John Poyhonen - CEO Sharon Wicker - SVP and Chief Commercial Development Officer">
<meta name='twitter:image' content='http://static1.cdn-seekingalpha.com/images/users_profile/000/101/639/big_pic.png?1361390225'><link rel="search" type="application/opensearchdescription+xml" href="/javascripts/seeking.xml" title="SeekingAlpha Search" />
<meta name="description" content="Senomyx, Inc. (SNXM) Q1 2014 Earnings Conference Call May 1, 2013 11:00 AM ET Executives Gwen Rosenberg - VP, IR and Corporate Communications John Poyhonen -" /><meta name="keywords" content="NASDAQ:SNMX" /><meta name="news_keywords" content="SNMX, Senomyx Inc., Services, Transcripts, United States, Food Wholesale" /><link rel="alternate" media="only screen and (max-width: 640px)" href="http://m.seekingalpha.com/article/2183003" /><meta name="syndication-source" content="http://seekingalpha.com/article/2183003-senomyxs-ceo-discusses-q1-2014-results-earnings-call-transcript"><meta property="og:image" content="http://static.cdn-seekingalpha.com/uploads/2013/8/19/social_sa_logo.png" />
<meta property="og:title" content="Senomyx's CEO Discusses Q1 2014 Results - Earnings Call Transcript" />
<meta property="og:description" content="Senomyx, Inc. (SNXM) Q1 2014 Earnings Conference Call May 1, 2013 11:00 AM ET Executives Gwen Rosenberg - VP, IR and Corporate Communications John Poyhonen - CEO Sharon Wicker - SVP and Chief Commercial Development Officer To" />
<link rel="canonical" href="http://seekingalpha.com/article/2183003-senomyxs-ceo-discusses-q1-2014-results-earnings-call-transcript" />
<meta name='viewport' content='width=1240'>

<script>
  window.PAGE_START_TS = new Date().getTime(); //will be put in mone
</script>

<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-5.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"c0370b1d43","applicationID":"334927,334964","transactionName":"cldeEUAJWgldEBsASkVRUwlXFRkWUA1D","queueTime":0,"applicationTime":58,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-400.min.js"}</script>
<script type="text/javascript">(window.NREUM||(NREUM={})).loader_config={xpid:"UwUUUlVXAQEH"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o?o:e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e){function n(t,e,n){n||(n={});for(var r=o[t],a=r&&r.length||0,s=n[i]||(n[i]={}),u=0;a>u;u++)r[u].apply(s,e);return s}function r(t,e){var n=o[t]||(o[t]=[]);n.push(e)}var o={},i="nr@context";e.exports={on:r,emit:n}},{}],2:[function(t){function e(t,e,o,a,u){return s?s-=1:n("err",[u||new UncaughtException(t,e,o)]),"function"==typeof i?i.apply(this,r(arguments)):!1}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}var n=t("handle"),r=t(6),o=t(5),i=window.onerror,a=!1,s=0;t("loader").features.push("err"),window.onerror=e;try{throw new Error}catch(u){"stack"in u&&(t(1),t(2),"addEventListener"in window&&t(3),window.XMLHttpRequest&&XMLHttpRequest.prototype&&XMLHttpRequest.prototype.addEventListener&&t(4),a=!0)}o.on("fn-start",function(){a&&(s+=1)}),o.on("fn-err",function(t,e,r){a&&(this.thrown=!0,n("err",[r,(new Date).getTime()]))}),o.on("fn-end",function(){a&&!this.thrown&&s>0&&(s-=1)}),o.on("internal-error",function(t){n("ierr",[t,(new Date).getTime(),!0])})},{1:5,2:4,3:3,4:6,5:1,6:14,handle:"D5DuLP",loader:"G9z0Bl"}],3:[function(t){function e(t){r.inPlace(t,["addEventListener","removeEventListener"],"-",n)}function n(t){return t[1]}var r=t(1),o=(t(3),t(2));if(e(window),"getPrototypeOf"in Object){for(var i=document;i&&!i.hasOwnProperty("addEventListener");)i=Object.getPrototypeOf(i);i&&e(i);for(var a=XMLHttpRequest.prototype;a&&!a.hasOwnProperty("addEventListener");)a=Object.getPrototypeOf(a);a&&e(a)}else XMLHttpRequest.prototype.hasOwnProperty("addEventListener")&&e(XMLHttpRequest.prototype);o.on("addEventListener-start",function(t){if(t[1]){var e=t[1];"function"==typeof e?this.wrapped=e["nr@wrapped"]?t[1]=e["nr@wrapped"]:e["nr@wrapped"]=t[1]=r(e,"fn-"):"function"==typeof e.handleEvent&&r.inPlace(e,["handleEvent"],"fn-")}}),o.on("removeEventListener-start",function(t){var e=this.wrapped;e&&(t[1]=e)})},{1:15,2:1,3:14}],4:[function(t){var e=(t(3),t(1)),n=t(2);e.inPlace(window,["requestAnimationFrame","mozRequestAnimationFrame","webkitRequestAnimationFrame","msRequestAnimationFrame"],"raf-"),n.on("raf-start",function(t){t[0]=e(t[0],"fn-")})},{1:15,2:1,3:14}],5:[function(t){function e(t){var e=t[0];"string"==typeof e&&(e=new Function(e)),t[0]=n(e,"fn-")}var n=(t(3),t(1)),r=t(2);n.inPlace(window,["setTimeout","setInterval","setImmediate"],"setTimer-"),r.on("setTimer-start",e)},{1:15,2:1,3:14}],6:[function(t){function e(){o.inPlace(this,s,"fn-")}function n(t,e){o.inPlace(e,["onreadystatechange"],"fn-")}function r(t,e){return e}var o=t(1),i=t(2),a=window.XMLHttpRequest,s=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"];window.XMLHttpRequest=function(t){var n=new a(t);return i.emit("new-xhr",[],n),o.inPlace(n,["addEventListener","removeEventListener"],"-",function(t,e){return e}),n.addEventListener("readystatechange",e,!1),n},window.XMLHttpRequest.prototype=a.prototype,o.inPlace(XMLHttpRequest.prototype,["open","send"],"-xhr-",r),i.on("send-xhr-start",n),i.on("open-xhr-start",n)},{1:15,2:1}],7:[function(t){function e(){function e(t){if("string"==typeof t&&t.length)return t.length;if("object"!=typeof t)return void 0;if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if("undefined"!=typeof FormData&&t instanceof FormData)return void 0;try{return JSON.stringify(t).length}catch(e){return void 0}}function n(t){var n=this.params,r=this.metrics;if(!this.ended){this.ended=!0;for(var i=0;u>i;i++)t.removeEventListener(s[i],this.listener,!1);if(!n.aborted){if(r.duration=(new Date).getTime()-this.startTime,4===t.readyState){n.status=t.status;var a=t.responseType,d="arraybuffer"===a||"blob"===a||"json"===a?t.response:t.responseText,p=e(d);if(p&&(r.rxSize=p),this.sameOrigin){var f=t.getResponseHeader("X-NewRelic-App-Data");f&&(n.cat=f.split(", ").pop())}}else n.status=0;r.cbTime=this.cbTime,o("xhr",[n,r])}}}function r(t,e){var n=i(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.sameOrigin=n.sameOrigin}t("loader").features.push("xhr");var o=t("handle"),i=t(1),a=t(5),s=["load","error","abort","timeout"],u=s.length,d=t(2);t(3),t(4),a.on("new-xhr",function(){this.totalCbs=0,this.called=0,this.cbTime=0,this.end=n,this.ended=!1,this.xhrGuids={}}),a.on("open-xhr-start",function(t){this.params={method:t[0]},r(this,t[1]),this.metrics={}}),a.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid)}),a.on("send-xhr-start",function(t,n){var r=this.metrics,o=t[0],i=this;if(r&&o){var d=e(o);d&&(r.txSize=d)}this.startTime=(new Date).getTime(),this.listener=function(t){try{"abort"===t.type&&(i.params.aborted=!0),("load"!==t.type||i.called===i.totalCbs&&(i.onloadCalled||"function"!=typeof n.onload))&&i.end(n)}catch(e){a.emit("internal-error",e)}};for(var p=0;u>p;p++)n.addEventListener(s[p],this.listener,!1)}),a.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),a.on("xhr-load-added",function(t,e){var n=""+d(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),a.on("xhr-load-removed",function(t,e){var n=""+d(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),a.on("addEventListener-end",function(t,e){e instanceof XMLHttpRequest&&"load"===t[0]&&a.emit("xhr-load-added",[t[1],t[2]],e)}),a.on("removeEventListener-end",function(t,e){e instanceof XMLHttpRequest&&"load"===t[0]&&a.emit("xhr-load-removed",[t[1],t[2]],e)}),a.on("fn-start",function(t,e,n){e instanceof XMLHttpRequest&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=(new Date).getTime()))}),a.on("fn-end",function(t,e){this.xhrCbStart&&a.emit("xhr-cb-time",[(new Date).getTime()-this.xhrCbStart,this.onload,e],e)})}window.XMLHttpRequest&&XMLHttpRequest.prototype&&XMLHttpRequest.prototype.addEventListener&&!/CriOS/.test(navigator.userAgent)&&e()},{1:8,2:11,3:3,4:6,5:1,handle:"D5DuLP",loader:"G9z0Bl"}],8:[function(t,e){e.exports=function(t){var e=document.createElement("a"),n=window.location,r={};e.href=t,r.port=e.port;var o=e.href.split("://");return!r.port&&o[1]&&(r.port=o[1].split("/")[0].split(":")[1]),r.port&&"0"!==r.port||(r.port="https"===o[0]?"443":"80"),r.hostname=e.hostname||n.hostname,r.pathname=e.pathname,"/"!==r.pathname.charAt(0)&&(r.pathname="/"+r.pathname),r.sameOrigin=!e.hostname||e.hostname===document.domain&&e.port===n.port&&e.protocol===n.protocol,r}},{}],handle:[function(t,e){e.exports=t("D5DuLP")},{}],D5DuLP:[function(t,e){function n(t,e){var n=r[t];return n?n.apply(this,e):(o[t]||(o[t]=[]),void o[t].push(e))}var r={},o={};e.exports=n,n.queues=o,n.handlers=r},{}],11:[function(t,e){function n(t){if(!t||"object"!=typeof t&&"function"!=typeof t)return-1;if(t===window)return 0;if(o.call(t,"__nr"))return t.__nr;try{return Object.defineProperty(t,"__nr",{value:r,writable:!0,enumerable:!1}),r}catch(e){return t.__nr=r,r}finally{r+=1}}var r=1,o=Object.prototype.hasOwnProperty;e.exports=n},{}],loader:[function(t,e){e.exports=t("G9z0Bl")},{}],G9z0Bl:[function(t,e){function n(){var t=c.info=NREUM.info;if(t&&t.agent&&t.licenseKey&&t.applicationID){c.proto="https"===f.split(":")[0]||t.sslForHttp?"https://":"http://",a("mark",["onload",i()]);var e=u.createElement("script");e.src=c.proto+t.agent,u.body.appendChild(e)}}function r(){"complete"===u.readyState&&o()}function o(){a("mark",["domContent",i()])}function i(){return(new Date).getTime()}var a=t("handle"),s=window,u=s.document,d="addEventListener",p="attachEvent",f=(""+location).split("?")[0],c=e.exports={offset:i(),origin:f,features:[]};u[d]?(u[d]("DOMContentLoaded",o,!1),s[d]("load",n,!1)):(u[p]("onreadystatechange",r),s[p]("onload",n)),a("mark",["firstbyte",i()])},{handle:"D5DuLP"}],14:[function(t,e){function n(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(0>o?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=n},{}],15:[function(t,e){function n(t,e,n,r){function nrWrapper(){try{var a,u=s(arguments),d=this,p=n&&n(u,d)||{}}catch(f){i([f,"",[u,d,r],p])}o(e+"start",[u,d,r],p);try{return a=t.apply(d,u)}catch(c){throw o(e+"err",[u,d,c],p),c}finally{o(e+"end",[u,d,a],p)}}return t&&"function"==typeof t&&t.apply&&!t._wrapped?(e||(e=""),nrWrapper._wrapped=!0,nrWrapper):t}function r(t,e,r,o){r||(r="");var i,a,s,u="-"===r.charAt(0);for(s=0;s<e.length;s++)a=e[s],i=t[a],i&&"function"==typeof i&&i.apply&&!i._wrapped&&(t[a]=n(i,u?a+r:r,o,a,t))}function o(t,e,n){try{a.emit(t,e,n)}catch(r){i([r,t,e,n])}}function i(t){try{a.emit("internal-error",t)}catch(e){}}var a=t(1),s=t(2);e.exports=n,n.inPlace=r},{1:1,2:14}]},{},["G9z0Bl",2,7]);</script>
<link href="http://static1.cdn-seekingalpha.com/stylesheets/packaged/performance_layout_packaged.css?1398841707" media="screen" rel="stylesheet" type="text/css" /><link href="http://static.cdn-seekingalpha.com/stylesheets/packaged/performance_layout_b_packaged.css?1398929817" media="screen" rel="stylesheet" type="text/css" /><link href="http://static.cdn-seekingalpha.com/stylesheets/packaged/article_packaged.css?1398841707" media="screen" rel="stylesheet" type="text/css" />
<script type="text/javascript">var siteon = false; var atest = true; var acounter = 0;</script>
<script type="text/javascript" src="/javascripts/siteon.js"></script>

<script type="text/javascript">
  var users_on_site='3,302,455';
  var user_cookie={};

  function readCookie(name) {
    var cookie = document.cookie.match(new RegExp('(^|;)\\s*' + escape(name) + '=([^;\\s]*)'));
    return (cookie ? unescape(cookie[2]) : null);
  }

  function addToCookie(key,value) {
    var arr=user_cookie[key].split(',');
    arr.push(value);

    user_cookie[key]=arr.join(',');
  }
  if (document.location.protocol == "https:") {
    document.write('<scr'+'ipt src="/account/no_cookie_key"></scri'+'pt>');
  } else if (readCookie('user_cookie_key')) {
    document.write('<scr'+'ipt src="http://static.cdn-seekingalpha.com/account/cookie/'+readCookie('user_cookie_key')+'"></scri'+'pt>');
  } else if (readCookie('user_id')) {
    document.write('<scr'+'ipt src="http://seekingalpha.com/account/no_cookie_key"></scri'+'pt>');
  }

  var isThisMyFirstPV = false;
  var _comscore = _comscore || [];
  _comscore.push({ c1: "2", c2: "8500672" });
  (function() {
    var s = document.createElement("script"), el = document.getElementsByTagName("script")[0]; s.async = true;
    s.src = (document.location.protocol == "https:" ? "https://sb" : "http://b") + ".scorecardresearch.com/beacon.js";
    el.parentNode.insertBefore(s, el);
  })();

  var is_pro = false;
  if (document.location.protocol == "https:") {
    document.write('<link rel="shortcut icon" type="image/ico" href="https://seekingalpha-a.akamaihd.net/favicon.ico" />')
  } else {
    document.write('<link rel="shortcut icon" type="image/ico" href="http://static.cdn-seekingalpha.com/favicon.ico" />')
  }


  var ASSET_HOSTS = ["http://static.cdn-seekingalpha.com","http://static1.cdn-seekingalpha.com","http://static2.cdn-seekingalpha.com","http://static3.cdn-seekingalpha.com"];
</script>

<script src="http://static1.cdn-seekingalpha.com/javascripts/packaged/common_packaged.js?1398841673" type="text/javascript"></script>
<script src="http://static.cdn-seekingalpha.com/javascripts/packaged/common2_packaged.js?1398868378" type="text/javascript"></script>
<script src="http://static2.cdn-seekingalpha.com/javascripts/packaged/coffee_packaged.js?1398848180" type="text/javascript"></script><script src="http://static2.cdn-seekingalpha.com/javascripts/packaged/common_article_packaged.js?1398929816" type="text/javascript"></script><script src="http://static.cdn-seekingalpha.com/memcached2/symbol_rt_data"></script>

<script src="//partner.googleadservices.com/gampad/google_service.js" type="text/javascript"></script>
<script>
  if (SA.Data && SA.Data.Cache) {
    var adata = SA.Data.Cache.get('campaign_content');
  }
  (function(){
    var url='/article/2183003-senomyxs-ceo-discusses-q1-2014-results-earnings-call-transcript';
    if (location.pathname!=url){
      if (window.history && history.replaceState) history.replaceState("", "", url+location.search);
      else location.href=url+location.search;
    }
  })();
</script>

<script type="text/javascript">
  if ((user_email_cookie=readCookie('user_email')) && user_email_cookie.indexOf('@gmail.com')!=-1) {
    createCookie('user_email',(user_email_cookie.replace('@gmail.com','').replace(/\./gi,'').replace(/\+(.*?)$/,''))+'@gmail.com',365);
  }

  if (typeof(readCookie) == "function" && readCookie('user_vocation')) {
    createCookie('u_voc',readCookie('user_vocation'),3000);
  }
  if (readCookie('sapu') == "121") {eraseCookie('sapu');}
  var user_cookie = user_cookie || {};
  eraseCookie("__article_last_size");

if (top.location.pathname == "/" && readCookie('user_id')==957061) {
  var old_SADataCookies = SA.Data.Cookies.get;
  SA.Data.Cookies.get = function(x){if (x=="user_following_users" || x=="user_watchlist_authors") return ""; else return old_SADataCookies(x);}
}
  try{(function(){
    var uc=SA.Data.Cookies.get("user_cookie_key"), t=uc ? uc.match(/t=([0-9]+)/) : null;
    if (t && t[1] < 1367771521) SA.Data.Cookies.set("user_cookie_key","");
  })();} catch(e){}

</script>


<link rel='alternate' href='android-app://com.seekingalpha.webwrapper/http/seekingalpha.com/article/2183003-senomyxs-ceo-discusses-q1-2014-results-earnings-call-transcript' />      <script type="text/javascript">
  var adblock = false;
  try{
    GS_googleAddAdSenseService("ca-pub-1420150919334552");
    GS_googleEnableAllServices();
  } catch(e) {
    adblock = true;
    Mone.event("Exception","adsense1","adsense down");
  }
</script>
<script type="text/javascript">
  try{
      GA_googleAddSlot_sa('transcript_120x30');
    GA_googleFetchAds();
  } catch(e) {
    adblock = true;
    Mone.event("Exception","adsense2","adsense down");
  }
</script>  </head>
    <body class="stretch_bg">
    <script>
  var ms_slug = '';
  var article_dashboards = 'transcript';
  var article_sectors_themes = '@transcripts@us@food-wholesale@services@article@';
  var ratings_hash={}
  var ARTICLE_ID = 2183003 ;
  var ARTICLE_TYPE = 'transcript';
  var ARTICLE_LOCK = "";
  var availableABVersions=["ver_a"];
  var abOBJ = new ABTest('transcript_pagination', availableABVersions);
  var machine_id = cookieExists('machine_cookie') ? parseInt(readCookie('machine_cookie')) : 0;
  var abVersion = abOBJ.value;
  var sliceSize = 4000;
  var isTranscript = true;
  var insight_article = false;

  try {window.sessionStorage.setItem("/article/"+ARTICLE_ID, '1');} 
  catch (error) {}
</script>
<script>var mone_article_tags = "{snmx};;;{services};;;{transcripts,us,food-wholesale};;;{sa-transcripts}"</script>

<script>var ord = Math.floor(Math.random()*1000000000);</script>
<span class="seeking_alpha_site_title">Seeking Alpha</span>
<script type="text/javascript">
  if (readCookie('sa_mobile') == '1') {
    var aHTML =[];
    aHTML.push('<div class="mobile_or_full_site">');
      aHTML.push('<span class="mobile_site" onclick="eraseCookie(\'sa_mobile\');top.location.reload()">Click here to view mobile site</span>');
      aHTML.push('<div class="cleaner"></div>');
    aHTML.push('</div>');
    document.write(aHTML.join(""));
  }
</script>
    <a href="sa://seekingalpha.com/article/2183003-senomyxs-ceo-discusses-q1-2014-results-earnings-call-transcript">
    <div id="smart_banner" style="display: none">
      <div id="ipad_smart_banner_ios6" onclick="SA.DeepLink.open_ipad_app('smart_banner')"></div>
      <div id="ipad_smart_banner_ios7" style="display: none" onclick="SA.DeepLink.open_ipad_app('smart_banner')"></div>
    </div>
  </a>

  <script>
    if (SA.Utils.Env.isIPad)  {
      $('smart_banner').show();
      Mone.event('ipad', SA.Utils.unifiedPath(), 'smart_banner_shown');
      var iosVersion = SA.Utils.Env.iosVersion().round();
      if(iosVersion > 6) var ipadVersion = 7;
      else var ipadVersion = 6;
      if (ipadVersion == 7){
        $('ipad_smart_banner_ios6').hide();
        $('ipad_smart_banner_ios7').show();
      }
      if(isArticle()){
        var element = $('ipad_smart_banner_ios'+ipadVersion);
        var backgroundImage = element.getStyle('background-image').split('?')[0].replace('url(','').replace(')','')
          .replace('.png','');
        backgroundImage = backgroundImage + '_article.png';
        if(backgroundImage)
        element.setStyle({
          'background': 'url(' + backgroundImage + ') no-repeat center',
          'background-size': '100%',
          'display': 'block',
          'height': '120px',
          'overflow': 'hidden',
          'text-decoration': 'none'
        })
      }
      SeekingAlpha.Initializer.AddAfterLoad(function(){
        if (SA.Utils.Env.isIPad && !/3/.test(SA.Data.Cookies.get("user_devices"))) {
          $$("body")[0].addClassName('ipad_promotion')
        }
      });

      function doOnOrientationChange() {
        switch(window.orientation)
        {
          case -90:
          case 90:
            if(isArticle()) $('header').setStyle({'margin-top': '120px'});
            else $('header').setStyle({'margin-top': '110px'});
            break;
          default:
            $('header').setStyle({'margin-top': '120px'});
        }
      }

      function isArticle(){
        return location.pathname.split('/')[1] === 'article';
      }

      window.addEventListener('orientationchange', doOnOrientationChange);
      setTimeout(doOnOrientationChange ,20);
    }
  </script>


<div id="header" class="not_logged_in header_nav">
  <div id="logo_and_navigation" class="logo_and_primary_navigation">
    <div id="comment_popup" style="position:relative; left:0; display:none">
  <div id="popup_secondary">
    <div id="inner_popup"></div>
  </div>
</div>    <span class="logo_old_h1"><a href="http://seekingalpha.com/" title="Seeking Alpha - Home Page" sasource="salogo"></a></span>
    
      <div class="item banner728x90" id='top_banner_728x90'>
          <script type="text/javascript">
            SA.Utils.Ads.add({el:$('top_banner_728x90'), HadCreated:false, size:'728x90', delta: null, NotSticky: true, info:'http://ad.doubleclick.net/N6001/adj/sek.earnings/reports;sz=728x90;x=x;tile=1;d=earnings;t=reports;aid=2183003;d=sectors;t=transcripts;t=us;t=food-wholesale;t=services;t=article;z=1;a=sa-transcripts;cnt=1;cnt=7;cnt=5;cnt=8;cnt=20;cnt=23;pr=snmx;s=snmx;'+dart_my_vocation_and_profiles()+'ord='+ord+'?', pos_key: 'sz=728x90,tile=1'});
            SA.Utils.Ads.run();
          </script>
      </div>
    
  </div>
  <div class='nav_container_wrap' id='nav_container_wrap'>
  <div id="nav_container" headtab="">
    <div id="navi_cont">
      <ul id="navi" class="navi">
        <li thistab='home' class="home">
          <a href="http://seekingalpha.com/" sasource="headtabs" style="font-size: 14px">Home</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='portfolio' class="portfolios">
          <a href="http://seekingalpha.com/account/portfolio" sasource="headtabs" style="font-size: 14px">My Portfolio</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='market_news'>
          <a href="http://seekingalpha.com/news/all" sasource="headtabs" style="font-size: 14px">Breaking News</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='analysis'>
          <a href="http://seekingalpha.com/analysis/all" sasource="headtabs" style="font-size: 14px">Latest Articles</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='stocktalks'>
          <a href="http://seekingalpha.com/stocktalks/all" sasource="headtabs" style="font-size: 14px">StockTalk</a>
          <span class="navi_right_corner">|</span>
        </li>

        <li thistab='alerts'>
          <a href="http://seekingalpha.com/real-time-alerts" sasource="headtabs" style="font-size: 13px">ALERTS</a>
            <span class="navi_right_corner">|</span>
          </li>
          <li thistab='pro' class="pro_tab">
            <a href="http://seekingalpha.com/account/pro" sasource="headtabs">PRO</a>
          </li>
        <li class="right_section">
          <div id="user_settings_wrapper"></div>
        </li>
      </ul>
    </div>
  </div>
    <div class="rta_nav">
      <span class="rta_nav_wrap">
        <div id="rta_nav_close" onclick="SA.Promotion.Sticky.hide()" class="close_rta">&nbsp;</div>
        <div id="related_promo_container_rel_nav" class="rta_bottom" style="display:none">
  <span class="title_wrap">
    <div class="rta_bottom_title" id="related_promo_title_nav">This transcript was sent to <span id="promo_num_of_rta_rel_nav">626</span> people who get email alerts on <span class="replace_by_rel_slug">&nbsp;</span>.</div>
      <div class="title_sec">Which cover: new articles | breaking news | earnings results | dividend announcements</div>
  </span>
  <div class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('rel_nav')">Get email alerts on <span class="replace_by_rel_slug">&nbsp;</span><span class='rta_bottom_arrow'> &raquo;</span></div>
  <div class="m_pop point_left" id="promotion_box_rel_nav" style="display:none;"></div>
</div>
<div id="related_promo_container_no_rel_nav" class="rta_bottom newsletter" style="display:none">
  <div class="rta_bottom_title">
    This transcript was sent to <span id="dash_newsl_subscr_count_ph_nav">&nbsp;</span> people who get the  newsletter.
    <span class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('no_rel_nav', null)">Get the  newsletter &raquo;</span>
    <span id="promo_no_rel_loader_nav" style="display:none;"><img height="16" width="16" src="http://static3.cdn-seekingalpha.com/images/loader.gif" /></span>
  </div>
  <div class="m_pop" id="promotion_box_no_rel_nav" style="display:none;"></div>
</div>
                              </span>
    </div>
</div>

  <script type="text/javascript">
    SeekingAlpha.Initializer.LogAndRun(SA.Navigation.Top.init);
  </script>
</div>

<div id="main_container" class="transcript_page">
    <script>
      if(window.screen.availWidth > 1260 || SA.Utils.Env.isIPad || SA.Utils.Env.isAndroid) $('main_container').addClassName('show_left_cont');
    </script>
     <div class='left_cont'>
        <div class="stickyad_wrapper">
          <div class="item banner160x600" id="fixed_banner160x600">
            <script type="text/javascript">
              function setAD(){
                if($('fixed_banner160x600').select('iframe')[0]) return;
                iframeAd("160x600",'http://ad.doubleclick.net/N6001/adj/sek.earnings/reports;sz=160x600;x=x;tile=3;d=earnings;t=reports;aid=2183003;d=sectors;t=transcripts;t=us;t=food-wholesale;t=services;t=article;z=1;a=sa-transcripts;cnt=1;cnt=7;cnt=5;cnt=8;cnt=20;cnt=23;pr=snmx;s=snmx;'+dart_my_vocation_and_profiles()+'ord='+ord+'?');
                Mone.article_shown_left_ad = true;
              }
              if(window.screen.availWidth > 1260 || SA.Utils.Env.isIPad || SA.Utils.Env.isAndroid) setAD();
            </script>
          </div>
        </div>
          </div>
  <div id="content_wrapper" itemscope itemtype="http://schema.org/Article" class="article_pages">
    <img src="http://static.cdn-seekingalpha.com/images/universal/print_logo.png" width="48" height="20" id="print_seekingalpha_logo" />
     <div id="main_content" class='no_big_gaps_main_content'>
      <div id="" class="no_big_gaps_secondary_ads">
        <div id='article_top_info'>
    <a href='/author/sa-transcripts' sasource='auth_header_pic'><img id='author_info_img' class="author_img" align="center" src="http://static1.cdn-seekingalpha.com/images/users_profile/000/101/639/big_pic.png?1361390225"></a>
    <div class='info_content'>
      <div>
        <a class='author_name' href='/author/sa-transcripts' id='author_info_name' rel='author' sasource='auth_header_name'>SA Transcripts</a>,
          <a class='author_nick link' href="http://seekingalpha.com/analysis/transcripts/all" target='_blank' onclick='if (!/@seekingalpha.com/.test(SA.Data.User.email())) Mone.event("article", "auth_header_link", "44211", {data: {"url":"http://seekingalpha.com/analysis/transcripts/all","text":"Recent earnings call transcripts","name":"SA Transcripts","bio":"We cover over 5K calls/quarter"}})'>Recent earnings call transcripts</a>
          <span class="clicks">(19,109 clicks)</span>
      </div>
      <div><span class='author_desc'>We cover over 5K calls/quarter</span></div>
      <div>
        <a href='/author/sa-transcripts' sasource='auth_header_profile' class="author_action">Profile</a><span class='sep'>|</span>
        <span class='author_action' onclick='Messaging.sendMessagePopup("1aoxskmd")'>Send Message</span><span class='sep'>|</span>
        <span id="msg_popup"></span>
        <span id='follow_btn' class="follow_button_author"></span>
        <span class='clicks'>(<span id='follow_clicks' class='follow_clicks_author'>1,754</span>)</span>
        <span style="position:relative">&nbsp;<span id="follow_loader" class="follow_loader_author" style="display:none"></span></span>
      </div>
      <div id="notify_favorite_authors" class="clicks fl cb" style="display: none">(You’ll be notified by email with new articles from your favorite authors.)</div>
      <div class='arr_up'></div>
    </div>
    <script>
      if (isTranscript)
        SA.Pages.Article.Follow.init('sa-transcripts');
      Mone.articleAuthorLinkShown = true;
      var author_version = ABTest.identity%10;
      $('follow_btn').observe('click', function(event) {
        unlock = null;
        if(this.className == 'link follow') {
          Mone.event("auth_follow", "article_auth_header", "follow_author");
          //will be used  after:
          //if (author_version == 1) {
          //  SA.Models.SubscriptionModel.subscribe(34909, "newsletters", "email preferences", unlock, unlock);
          //}
        }
        else if (this.className == 'link unfollow') {
          Mone.event("auth_follow", "article_auth_header", "stop_follow_author");
        }
      });

    </script>
</div>



      </div>
       <div id='top_author_details'>
         <div id="article_header" class="article_content">
  <div class="top_content">
    <div id="page_header" class="page_header_email_alerts">
      <h1>
        <span itemprop="name">Senomyx&#x27;s CEO Discusses Q1 2014 Results - Earnings Call Transcript</span>
              </h1>
      <div id="article_info">
        <div class="article_info_pos">
          <span>May.  1, 2014  3:02 PM ET</span>
          <span class='print_hide'>&nbsp;|&nbsp;</span>
          <span id='title_article_comments'></span>
              <span class="print_hide">
                <span>About:</span> <span id='about_primary_stocks'><a href="/symbol/SNMX" title='Senomyx, Inc.' sasource='article_primary_about_trc'>SNMX</a></span>                              </span>
          <span class="author_name_for_print">by: SA Transcripts </span>
          <span id="second_line_wrapper">
          </span>
        </div>
        <div class="article_disclosure">
          
        </div>
      </div>
    </div>
  </div>
</div>
<div class="cleaner"></div>

       </div>
        <div id="article_body_container" class="no_big_gaps_article_body_container">
          <div id="article_body" itemprop="articleBody">
            <div id="article_participants" class="content_part hid">
  <p><strong>Executives</strong></p>
<p></p>
<p>Gwen Rosenberg - VP, IR and Corporate Communications</p>
<p>John Poyhonen - CEO</p>
<p>Sharon Wicker - SVP and Chief Commercial Development Officer</p>
<p>Tony Rogers - SVP and CFO</p>
<p></p>
<p><strong>Analyst</strong></p>
<p></p>
<p>Scott Henry - ROTH Capital Partners</p>
<p>Justin Ruiss – Sidoti &amp; Company</p>
<p></p>
</div>

<div id="article_content" class="content_part hid">
  <p>Senomyx, Inc. (SNXM) Q1 2014 Earnings Conference Call May  1, 2013 11:00 AM ET</p><p><strong>Operator</strong></p>
<p>Good morning. We will now begin the Senomyx Conference Call. At this time, I would like to inform you that this conference is being recorded and that all participants are in a listen-only mode. At the request of the company, we will open the conference up for questions-and-answers after the presentation. (Operator Instructions). I would now like to turn the call over to Gwen Rosenberg, Senomyx's Vice President of Investor Relations and Corporate Communications.</p>
<p><strong>Gwen Rosenberg</strong></p>
<p>Good morning and welcome to the Senomyx first quarter 2014 earnings and corporate update conference call. Participating on this call from Senomyx will be John Poyhonen, Chief Executive Officer; Sharon Wicker, Senior Vice President, Chief Commercial Development Officer; Tony Rogers, Senior Vice President and Chief Financial Officer and Don Karanewsky, Senior Vice President Discovery and Chief Scientific Officer.</p>
<p>Before we begin, please note that during the course of this call, we may make projections or other forward-looking statements regarding future events or financial performance of the company that involve risks and uncertainties. The company's actual results may differ materially from the projections described in this morning's press release and this conference call.</p>
<p>Factors that might cause such a difference include, but are not limited to those discussed in our quarterly and annual reports filed with the SEC. Copies of these documents are available upon request from Investor Relations at Senomyx or may be accessed via our web site, at www.senomyx.com.</p>
<p>I'd now like to turn the discussion over to John Poyhonen, CEO of Senomyx.</p>
<p><strong>John Poyhonen</strong></p>
<p></p>
<p>Thank you Gwen, good morning to everyone and thank you joining the Senomyx Management team for our conference call and webcast. During our last earnings call we introduced three key areas that our efforts will be focused on during 2014. The first quarter of the year was very eventful for Senomyx and we'll start this call with progress that we've made in each of these three focus areas.</p>
<p>First we're continuing to grow, protect and maximize our unmatched expertise and taste science technologies. Senomyx's proprietary technology platform has enabled discovery as an innovative flavor ingredients in the areas of sweet, savory, bitter and cooling taste. We're building on this success with our current research activities. And our Sweet Taste program Senomyx is working to discover additional novel flavors with modifying properties that could create incremental value such as allowing for an even greater reduction of sweeteners or lower cost and use at our current sweet flavor modifiers.</p>
<p>We're evaluating a number of new sucrose and fructose modifiers that posses advantageous properties in our potential candidates for development activities. We have also identified several natural sucrose modifiers and natural high intensity sweeteners that provide taste proof of concept and validate the methodologies we're using for the natural products components of our sweet taste program.</p>
<p>Ongoing activities in this project includes scale up of additional material of the most promising natural discoveries to further characterize the taste and physical properties. This evaluation process will be important as we assess the viability of our current discoveries. In addition we're continuing our efforts related to further expansion of Senomyx's natural product library, (tight group) [ph] of screening of selected (plant to rock) [ph] samples and [indiscernible] with samples of interest.</p>
<p>In our cooling program we're moving forward with development activities for S2227 a novel cooling agent that has aroma and taste advantages over currently available agents. We're also evaluating additional new cooling agents discovered by Senomyx for potential future development. </p>
<p>Senomyx's salt taste program is an important part of the Company's research activities. Our current objective is to discover the specific protein or group of proteins that function to detect salt in foods. This protein or proteins can then serve as research targets to discover new salt flavor modifiers using Senomyx's flavor technologies.</p>
<p>Starting with the large proprietary database of proteins found in taste buds Senomyx has identified a small group of proteins that meet certain criteria or potentially being involved in salt taste. We're making progress as we evaluate each of these candidate targets to see if modifiers can be identified and lead us to a taste proof concept which would validate a salty taste target. The ultimate goal is to indentify flavors with modifying properties that can restore the desired salty taste in products with reduced salt.</p>
<p>In April Senomyx announced that we had entered into a new research agreement with PepsiCo related to the salt taste program. PepsiCo has been a value partner for our Sweet Taste program and we're very pleased to extend our relationship into an additional taste area.</p>
<p>This is a new type of research agreement for Senomyx with both near-term funding and potential long term benefits for the company. PepsiCo will contribute funding for the salt taste program throughout 2014 and they have options to continue the research funding for up to three additional years.</p>
<p>PepsiCo will have non-exclusive rights to salt flavor modifiers discovered during the research funding period for use in all of their products worldwide.</p>
<p>In addition, they will receive a two year period of exclusivity for use, of each of these flavor modifiers in snack foods and snack dips. Importantly salt flavor modifiers discovered under this agreement could be added to Senomyx's a direct portfolio.</p>
<p>We retain significant freedom to operate which will allow Senomyx to market these salt flavor modifiers as a solution for a company seeking to retain great taste in a wide variety of lower sodium products.</p>
<p>In addition we have the right to supply the salt flavor modifiers directly to PepsiCo. This provision will allow Senomyx to establish commercial manufacturing capabilities through a third party which will be beneficial to our direct sales activities.</p>
<p>Senomyx's second area of focus is the expansion of our flavor ingredients pipeline for collaborators and flavor industry customers. Senomyx flavors are unique in their ability to create a competitive advantage by enabling an improved nutritional profile, better taste or lower cost in a broad range of food and beverage products.</p>
<p>As we discussed in our March call, our S617 Sweetmyx flavor ingredient is the most recent and potentially the most valuable of all our ingredients discovered to date. It has utility for our broad range of non-alcoholic beverages, alcoholic beverages in a wide variety of foods. The recent FEMA GRAS regulatory designation allows immediate use of the Sweetmyx flavor ingredient in the U.S. and a number of other countries.</p>
<p>While we cannot discuss any specifics regarding commercialization plans at this time, Senomyx is working with our partners as they evaluate potential product opportunities for the new Sweetmyx flavor ingredient.</p>
<p>PepsiCo has exclusive rights to use this ingredient worldwide in non-alcoholic beverages, Firmenich has commercialization rights for food products and alcoholic beverages with exclusive rights until March 2018. At which time Senomyx will be able to market Sweetmyx S617 to flavor companies for food applications.</p>
<p>We've also extended our current flavoring ingredient portfolio for Senomyx's direct sales customers. During the past quarter we began introducing additional flavor offerings to flavor companies thereby broadening our ability to address their needs for innovative flavor solutions.</p>
<p>Senomyx's third area of focus is the successful implementation of the direct sales program, as measured by our ability to drive commercial revenues. Our direct sales efforts involved, presenting Senomyx's ingredients to flavor companies that create proprietary flavor systems for their food and beverage company clients.</p>
<p>We are very encouraged by the response from flavor companies that have begun in valuations of our ingredients. </p>
<p>I will now turn the call over to Sharon Wicker who will address Senomyx's commercialization activities. She will be followed by Tony Rogers who will review our financial status and outlook and I will return after the Q&amp;A section for a few closing remarks at the end of the call. Sharon?</p>
<p><strong>Sharon Wicker</strong></p>
<p>Thank you, John. We are excited about Senomyx's direct sales program which is gaining momentum with further evaluations of our ingredients high flavor companies, including addition of the new offerings that John just mentioned.</p>
<p>Our Complimyx taste modulation ingredients brand now includes two Senomyx's Sweetmyx sucrose modifiers, as well as a Savorymyx savory flavor and a Bittermyx Bitter Blocker. Commercialization activities were initiated recently with Sweetmyx SR69, also known as S6973, which is used to maintain the sweet taste in reduced-sugar products.</p>
<p>Two key benefits of Sweetmyx SR69 are that it has been granted regulatory approvals in nearly every major country, and it is the first sucrose modifier in our direct sales portfolio being promoted for use in food products. </p>
<p>SR69 is applicable for use in numerous food product categories, including baked goods, confectionaries, cereals and dairy products, such as yogurt and ice cream. According to [indiscernible] monitor global use of sucrose across targeted food product categories is approximately 17 million metric tons on an annual basis.</p>
<p>We estimate that our existing regulatory approvals allow for the commercialization at SR69 in more than 90% of the target market opportunity. We expect to receive initial commercial scale quantities of SR69 from our manufacturer by mid-year 2014. SR69 is an excellent complement to Sweetmyx, SR96 also known as S9632 another effective sucrose modifier that we are currently marketing for use with reduced sugar beverages.</p>
<p>Targeted product categories for SR96, include ready-to-drink and powdered forms of coffee, tea and flavored milk, powdered soft drinks and dairy beverages. According to our research, these target product categories use more than 5.2 million metric tons of sucrose on an annual basis.</p>
<p>We estimate that each global market share point is worth approximately $8 million to us in direct sales revenues. Furthermore, we estimate that our current regulatory approvals allow for the commercialization of SR96 in approximately 30% of the target market opportunity at this time.</p>
<p>Commercial scale quantities of SR96 have been received from our contract manufacturer. SR69 and SR96 are each highly affected in restoring the desired flavor profile of products where sugar has been reduced. Having both of these novel ingredients in our Sweetmyx portfolio allows Senomyx to address multiple food and beverage product requirements and become a valuable resource for our flavor company customers. We are also pleased with the feedback from flavor companies to Savorymyx UM80. This novel savory flavor can be used to replace monosodium glutamate or MSG and can also be combined with other flavor ingredients to create unique savory flavor blends.</p>
<p>UM80 has virtually global regulatory approvals and is applicable for a wide variety of products including sauces, seasoning blends, frozen foods, cooking aids, soups and snack food. UM80 is very versatile and can also allow manufacturers to achieve a cost savings compared to MSG. MSG consumption during 2012 was more than 2.4 million metric tonnes. We estimate that each global market share point is worth approximately $2 million to us in direct sales revenues. In addition we estimate that our existing regulatory approvals allow for the commercialization of UM80 in more than 90% of the target market opportunity.</p>
<p>Evaluations of UM80 are underway in the U.S. and other geographies for use in a range of food and beverage product categories. Senomyx has received commercial inventory quantities of UM80 from a global manufacturer to support our sales and marketing efforts. Most recently Senomyx has started selling our Bittermyx BB68 Bitter Blockers to potential flavor company customers. </p>
<p>BB68 can be used as part of a flavor system for foods and beverages to reduce the bitterness of ingredients such as hydrolyzed soy and whey proteins, menthol, caffeine, cocoa, and stevia reducing the bitterness of high-protein products is especially helpful for manufacturers of value added nutritionally based products.</p>
<p>In summary we are making good headway with our efforts to leverage Senomyx's proprietary taste science technologies to become a leading commercial provider of novel flavor ingredients to the flavor industry. Feedback from the flavor companies has been positive and we believe we've had an excellent start towards this goal. More specifically we continue to receive a high level of interest from our customers to conduct evaluations across all of our flavor offerings.</p>
<p>Additionally many of our customers have requested price quotations and access to complete supplier authorization surveys. Both of these actions are typically required before purchase orders can be placed. We believe that this activity along with the modest initial orders we have received from flavor companies represent encouraging signs with the future placement of larger orders.</p>
<p>I look forward to providing further updates regarding our direct sales on our next earnings call.</p>
<p>Turning to our royalty based collaborations; Senomyx continues to receive commercial revenues from Firmenich, Nestlé and Ajinomoto on sales of their products incorporating our flavor ingredients. In brief as indicated in today's press release, our partners are continuing to conduct commercialization activities with Senomyx's S6973 and S9632 sucrose modifiers as well as S2383 a modifier of the commonly used high intensity sweeteners sucralose S336, the savory flavor and our S6821 Bitter Blocker.</p>
<p>I will now turn the discussion to Tony Rogers Senomyx's CFO who will provide an overview of our financial status and outlook. Tony.</p>
<p><strong>Tony Rogers</strong></p>
<p></p>
<p>Thank you Sharon. Financial results for the first quarter of 2014 met or exceeded management expectations and we're on track to achieve our financial guidance. At March 31, 2014 Senomyx held $31.6 million in cash, cash equivalents and investments available for sale. Total revenues were $8.2 million for the first quarter ended March 31, 2014 compared to 7.5 million for the same period in 2013. The increase primarily resulted from $1.3 million of development milestones earned in the first quarter of 2014 related to the Sweet Taste program.</p>
<p>This increase was partially offset by a decrease in development revenues related to Senomyx's cooling taste program as research fundings under the company's cooling taste program collaboration with Firmenich expired in June 2013. Total commercial revenues in the first quarter 2014 were $1.4 million which were primarily from our royalty based collaborations. During the first quarter we recorded revenue associated with direct sales to flavor companies.</p>
<p>As expected, these initial sales were modest, we continue to make promising incremental progress and we expect the direct sales will be a key driver of commercial revenue growth in the future. Research, development and patents expense including stock based expenses were $7 million for the first quarter of 2014 compared to $7.4 million in the first quarter of 2013. The primary factor for the decrease from 2013 to 2014 was reduced outside services cost for safety study to support regulatory filings.</p>
<p>Selling, general and administrative expenses were 3.1 million for the first quarter of 2014 and 3 million for the first quarter of 2013. The increase was primarily due to increased non-cash stock based expenses in 2014 resulting from a higher fair value for stock options granted in 2014 based on the higher price of Senomyx's common stock. The net loss for the quarter ended March 31, 2014 improved to $0.05 per share compared to $0.07 per share for the quarter ended March 31, 2013. </p>
<p>Regarding our financial guidance for the full year 2014 Senomyx continues to expect total revenues of $32 million to $35 million of which approximately 10 million are commercial revenues. Our commercial revenues will be weighted towards the end of the year and our guidance assumes S617 will be commercialized by one of our partners in the second half of 2014.</p>
<p>We also expect total operating expenses of 44 million to 46 million of which approximately 6 million is non-cash stock based expense. Our net loss is anticipated to be 10 million to 12 million resulting in basic and diluted net loss of $0.23 to $0.28 per share. We expect to end the year with more than $25 million in cash, cash equivalents and investments available for sale. With $31.6 million in cash, no debt and significant development funding commitment from our collaborators going forward, Senomyx remains well positioned to achieve our discovery development commercialization objectives including our goal to achieve approximately $25 million in commercial revenues in 2015 and importantly our goal to achieve profitability in 2015.</p>
<p>I will now turn the call back over to the operator to open up for questions.</p>
</div>

<div id="article_qanda" class="content_part hid">
  <p><strong>Question-and-Answer Session</strong></p>
<p><strong>Operator</strong></p>
<p>(Operator Instructions) Please stand by for your first question Mr. Poyhonen. Our first question comes from Scott Henry of ROTH Capital.</p>
<p><strong>Scott Henry - ROTH Capital Partners</strong></p>
<p>Thank you and good morning. Just a couple of questions, first I mean there is -- congratulations on -- there's been a lot of progress in the past year. And there is just a lot of information in the press release and a lot on the call. If you could boil it down to kind of the main one or two things that have happened in the pipeline over the past quarter, what would it be? I am just trying to get an idea of where you want us as investors to focus?</p>
<p><strong>John Poyhonen</strong></p>
<p>Good morning Scott, this is John. I think that really the key developments that we've had in the first four months of the year really are in three areas starting with the approval of Sweetmyx S617 as you know we received (thermograph) [ph] determination of that and announced that in March. That's critical for us as a company it's our first sweet modifier that works both with sucrose and fructose and allows for a wide use in a wide range of non-alcoholic beverages as well as alcoholic beverages and food product. So I think that stands out as the number one accomplishments. </p>
<p>Number two, I think we're very excited about the new products that we've added to our direct sales portfolio with the approval of S617 we were able to regain rights from Firmenich of SR69, our sucrose modifier to use in food products globally because of regulatory approval and we've also added the Bitter Blocker BB68. So really being able to round out our portfolio from our perspective is very critical. </p>
<p>And then finally we're very excited about the progress that we're making from an R&amp;D standpoint, both of these are more challenging projects that I'll reference the salt I think we made very good progress and really narrowing down the potential salty taste targets and I think that's represented by the new agreement that we have with PepsiCo and I think we're doing some really interesting things from a natural perspective too. So, I think all in all the company is very pleased with where we're at and the progress that we've made during the first four months of the year.</p>
<p><strong>Scott Henry - ROTH Capital Partners</strong></p>
<p>Okay, thank you. That was helpful. I guess now getting into some of the specifics, commercial revenues were certainly stronger than expected 1.4 million versus 800,000 last quarter. Is that just the seasonality there because I see it was 1.4 million in first quarter '13 and it seems like -- just trying to get an idea is that fundamental upside or how should I think about that?</p>
<p><strong>John Poyhonen</strong></p>
<p>Scott I'll have Tony Rogers address that.</p>
<p><strong>Tony Rogers</strong></p>
<p>Hi, Scott. No, I wouldn't define it as seasonality. I would say using your words is more of a fundamental upside, again we're tracking to 10 million for this year of commercial revenues, so I think that puts us on pace towards that target.</p>
<p><strong>Scott Henry – ROTH Capital Partners</strong></p>
<p>Okay. So you would expect to see sequential growth in Q2?</p>
<p><strong>Tony Rogers</strong></p>
<p>I think we'll have 10 million for the full year. I am not going to define and describe second quarter but I think we'll have 10 million for the full year.</p>
<p><strong>John Poyhonen</strong></p>
<p>Scott maybe just a little more clarity on that too if you look at the first quarter year over year, during 2013 we actually had a higher minimum annual royalty that we had from one partner before we reacquired rights, so really when you look at all other aspects of our commercial revenue we're growing in the first quarter compared to 2013 but please keep in mind that once guided that we think that the commercial revenue will be heavily weighted to the backend.</p>
<p><strong>Scott Henry – ROTH Capital Partners</strong></p>
<p>Okay, that's helpful. And I think, the way I interpreted your discussion on direct orders, is we should see some revenues, albeit quite modest in the second quarter of '14 or will you book revenues in second quarter '14 for direct sales?</p>
<p><strong>John Poyhonen</strong></p>
<p>Yes, we booked revenues in the first quarter, Scott for direct sales.</p>
<p><strong>Scott Henry – ROTH Capital Partners</strong></p>
<p>Okay. You did.</p>
<p><strong>John Poyhonen</strong></p>
<p>And we expect to book them going forward.</p>
<p><strong>Scott Henry – ROTH Capital Partners</strong></p>
<p>Okay. Would you -- is that disclosed in the 10-Q or could you talk about what, the mix of that 1404 between direct and commercial?</p>
<p><strong>John Poyhonen</strong></p>
<p>No, we haven't got into the details on the composition of commercial revenue. I expect at some point going forward we will get into those details. You can look at our gross margin we've guided for gross margin of 75% to 85% for the full year. You can look at our historic gross margins and arrive at some level of understanding.</p>
<p><strong>Scott Henry – ROTH Capital Partners</strong></p>
<p>Okay. Well, I guess since it's been 93% the last five quarters; I can infer that direct sales were probably miniscule in this quarter.</p>
<p><strong>John Poyhonen</strong></p>
<p>They are modest, yes.</p>
<p><strong>Tony Rogers</strong></p>
<p>Yes, and Scott, keep in mind these first quarter orders that we have were primarily reorders from flavor companies who had already been conducting evaluations through a material transfer agreement. So they were ordering small quantities to actually continue their work with our flavors and also respond briefs from their customers. So its smaller orders and I think as we progress during the year, as Sharon referred to, we're seeing positive signs that we think larger orders will be coming later in 2014.</p>
<p><strong>Scott Henry – ROTH Capital Partners</strong></p>
<p>Okay. Great. And I guess, the final question I just wanted to, try and ask a couple of questions about the Pepsi program because those are the questions that come to me often. First, is the Sweet taste program collaboration, does the first option for Pepsi to decide to continue or not, does that come up in August of 2014. This was the questions that came to me and I just wanted to confirm that.</p>
<p><strong>John Poyhonen</strong></p>
<p>Yes, the initial research funding period was four years and runs through August of 2014. PepsiCo has a one-time option to expand for two years and they'll have to provide us with written notification before the expiration at that time.</p>
<p><strong>Scott Henry – ROTH Capital Partners</strong></p>
<p>Okay. But I would gather, since you -- the product's being approved and you're assuming commercialization in second half '14, that sounds like a formality, is that kind of, I guess you can't answer for someone else?</p>
<p><strong>John Poyhonen</strong></p>
<p>Well, you know we can't speak for PepsiCo but I think that we've made tremendous progress in our sweet program and we hope that they are as pleased with the progress as we are, we would expect, they would extent.</p>
<p><strong>Scott Henry – ROTH Capital Partners</strong></p>
<p>Okay. And that certainly makes sense. And I just wanted to ask as well, congratulations on the salt taste agreement, certainly a positive development for you. I am curious how that came about, I mean was Pepsi impressed by the way the sweet taste program was or was it a couple of specific molecules or the just kind of a pilot study to see what you can do in the rest of the year, just any color would be beneficial.</p>
<p><strong>John Poyhonen</strong></p>
<p>Yes, I think one of the benefits of being our partner with Senomyx is that you have earlier access to discovery efforts in other programs and certainly we do that with all of our partners where there is mutual interest. So I think it was overtime we just continued to keep them up to date on the progress that we were making with the program. And you know we're very pleased to have them as a partner funding our research there with our efforts through the remainder of this year. They have options during that to fund for up to an additional three years beyond that.</p>
<p><strong>Operator</strong></p>
<p>Thank you. The next question comes from [indiscernible] of Needham Company.</p>
<p><strong>Unidentified Analyst</strong></p>
<p><strong> </strong></p>
<p>Just a couple of questions, I guess a few more on the new PepsiCo research collaboration. Just wanted to know, how it impacts your ongoing research in a salt taste program. And then I guess, the current terms for the collaboration for 2014, just trying to get an idea of timelines for extensions, I know they are similar to the other PepsiCo collaboration on the sweet taste program?</p>
<p><strong>Tony Rogers</strong></p>
<p>So on the efforts on the salt taste program, I think the first thing that I just want to continue to confirm is that, our number one objective is validating a salty taste receptor and we won't do that until we have a taste proof of concept. </p>
<p>We've worked through a proprietary database of over 25,000 proteins and the team's done a tremendous job with analytical approaches that has allowed us to get to a very manageable number of candidates for doing that. But we still have to do the work on those candidates and make sure one of those proteins or a group of proteins actually provides the desired impact on salty taste. So that's ongoing, we are doing work with that. We're screaming against those candidates and the challenge of research is you don't know until you found it, so the timing is very difficult to estimate. The way that the agreement is set up with PepsiCo is flexibility based on progress with the program where they would have the ability to extend beyond their initial funding period and that's really all the details we've disclosed at this point.</p>
<p><strong>Unidentified Analyst</strong></p>
<p>Okay, I guess a few on direct sales. If you add new flavor ingredients to the portfolio across -- you have a sweet savory and Bitter Blocker ingredients, do you expect the evaluation periods to be the same across every category?</p>
<p><strong>John Poyhonen</strong></p>
<p>Maybe I'll ask Sharon Wicker to address that.</p>
<p><strong>Sharon Wicker</strong></p>
<p>Sure. So, we have the four ingredients and of course a couple of these have been in the portfolio for a longer period of time. So just in terms of kind of where we are in the sequence that would be SR96 and UM80. </p>
<p>So there has just kind of been a more of a head start in terms of working with those ingredients. We've mentioned that we of course recently started promoting and selling an additional sweet mix offering SR69 and then the bitter mix offering BB68. </p>
<p>So a lot of interest in those but those are just more or less getting off the ground, so that's just sort of one kind of your question of the sequence within entering the portfolio. I think in terms of each ingredient on its own the flavor house companies bring them in, they start to do their own characterization work, a lot of it is opportunistic probably around briefs they have or projects they're working on for their customers. So if they've got an opportunity for sucrose reduction product which is a pot area then maybe that would take a lead in terms of working its way through the process. So I think it's kind of hard to say that. It really just depends on what they're focusing on and their customers' needs and how our ingredients fit in with that.</p>
<p><strong>Operator </strong></p>
<p>Thank you. The next question comes from Justin Ruiss of Sidoti.</p>
<p><strong>Justin Ruiss – Sidoti &amp; Company</strong></p>
<p>Good morning. Thanks for taking my questions. Actually just had a quick one that kind of is a follow up to what was just answered before. But I know that with the direct selling program, it seems like you're kind of going through a lot of like paper work and regulation bureaucracy kind of, is there any way that you can accelerate that portion of it or does it just -- is that just the way that the flavor companies operate?</p>
<p><strong>John Poyhonen</strong></p>
<p>Well, maybe I'll start off and then I'll let Sharon hop in. I think that the flavor companies have -- all have a unique capabilities and proprietary technology and knowhow that they use with their customers and it takes time to incorporate our flavor ingredients into what they're doing. So we're very pleased with the amount of investment and resources that they're putting on the program. Ultimately though there is two ways they can gain the business, they can respond to a brief from their food and beverage clients or they can also do something more proactively where they try to push new solutions. And I think it will be a combination but obviously I think the quickest way is one they're responding to a brief since there is already an existing need that's been identified with a food and beverage company.</p>
<p>So we feel like they are going after this pretty aggressively, we've been pleased with the progress that they're making, but ultimately it all comes down to a food and beverage company deciding that they want to incorporate it into their products. And that's something that they don't have complete control over as well. </p>
<p>So I think that our turnaround here has been exceptional. When we're getting these documents our team is turning it over in a day or two so it's -- and these are 30 page documents. So we're pretty happy with that when they're asking for samples or placing orders, we're turning that around. The process is in place, so I don't know that there is anything that we can do to really accelerate that other than the fact that we are doing some efforts now also with consumer product companies from a pull standpoint where we're doing demonstrations and hopefully they'll try to pull that through their flavor companies.</p>
<p><strong>Operator</strong></p>
<p>At this time there are no further questions. So I'll turn the call back to Mr. Poyhonen to conclude.</p>
<p><strong>John Poyhonen</strong></p>
<p>I'd like to thank you all for participating in our call today and leave you with a few highlights regarding Senomyx's progress on our three key areas of focus for 2014. Our focus on Senomyx's patented key science technologies continues to drive our discovery activities and yield novel flavor ingredients that differentiate Senomyx from other flavor companies. We're making significant strides in our sweet taste program with new discoveries and promising advances with our natural flavor ingredients efforts. </p>
<p>We also welcome PepsiCo as our new partner on our Salt Taste Program. Senomyx's scientific expertise enables the continuing expansion of our pipeline of innovative flavor ingredients. Our Complimyx taste modulation ingredients brand now includes two complementary Sweetmyx sweet taste modifiers, a Savorymyx savory flavor and a Bitter Blocker. These offerings can address multiple challenges faced by the food and beverage industry. </p>
<p>Lastly, we've increased our efforts to the successful implementation of Senomyx's direct sales program. We are pleased with the positive reception of flavor companies to Senomyx's sales activities. We're building awareness of our brand while conducting evaluations at Senomyx's ingredients with key flavor companies, as well as demonstrations with selected consumer product companies that can help create demand for our offerings. </p>
<p>In summary, the first quarter of 2014 has been a promising beginning for the year and the company's future success. We thank you for your interest in Senomyx and look forward to updating you on our next earnings call.</p>
<p><strong>Operator</strong></p>
<p></p>
<p>Ladies and gentlemen, this concludes our conference call for today. All parties may now disconnect. </p>
</div>

<div id="article_disclaimer" class="content_part hid">
  
<p><strong>Copyright policy: </strong>All transcripts on this site are the copyright of Seeking Alpha. However, we view them as an important resource for bloggers and journalists, and are excited to contribute to the democratization of financial information on the Internet. (Until now investors have had to pay thousands of dollars in subscription fees for transcripts.) So our reproduction policy is as follows: <strong>You may quote up to 400 words of any transcript on the condition that you attribute the transcript to Seeking Alpha and either link to the original transcript or to www.SeekingAlpha.com. All other use is prohibited.</strong></p>

<p>THE INFORMATION CONTAINED HERE IS A TEXTUAL REPRESENTATION OF THE APPLICABLE COMPANY'S CONFERENCE CALL, CONFERENCE PRESENTATION OR OTHER AUDIO PRESENTATION, AND WHILE EFFORTS ARE MADE TO PROVIDE AN ACCURATE TRANSCRIPTION, THERE MAY BE MATERIAL ERRORS, OMISSIONS, OR INACCURACIES IN THE REPORTING OF THE SUBSTANCE OF THE AUDIO PRESENTATIONS. IN NO WAY DOES SEEKING ALPHA ASSUME ANY RESPONSIBILITY FOR ANY INVESTMENT OR OTHER DECISIONS MADE BASED UPON THE INFORMATION PROVIDED ON THIS WEB SITE OR IN ANY TRANSCRIPT. USERS ARE ADVISED TO REVIEW THE APPLICABLE COMPANY'S AUDIO PRESENTATION ITSELF AND THE APPLICABLE COMPANY'S SEC FILINGS BEFORE MAKING ANY INVESTMENT OR OTHER DECISIONS.</p>
<p>If you have any additional questions about our online transcripts, please contact us at: <a href="mailto:transcripts@seekingalpha.com" rel="nofollow"><u>transcripts@seekingalpha.com</u></a>. Thank you!</p>

</div>

<div id="article_slice"></div>

<div class="cleaner"></div>

              <div id="article_source">Source: <a href="/article/2183003-senomyxs-ceo-discusses-q1-2014-results-earnings-call-transcript?source=cc">Senomyx&#x27;s CEO Discusses Q1 2014 Results - Earnings Call Transcript</a></div>
          </div>
          <div class="cleaner"></div>
          <div class="transcript_bottom_tabs">
            <ul id="tab_cmd" style="float:left;display:none;">
              <li id="tab_single_bottom" name="tab_single" style="border-width:0px !important;" onclick='if (SA.Data.User.loggedIn()) {transcriptRedirect("single")} else {transcript_rb_show()}'><span>Single page view</span></li>
              <li id="tab_search_bottom" class="last chosen" name="tab_search" style='display:none;border-left: 1px solid #C4C4C4;'><span>Search</span></li>
            </ul>
            <div id="pag_cmd" style="display:none;">
            	<div id="tab_prev_bottom" name="tab_prev" style="display:none;float:left"><a href="javascript:void(0)" onclick="abOBJ.convert('Prev Page');trascriptNextSlice(-1)">&laquo; Previous</a>&nbsp;|&nbsp;</div>
            	<div id="tab_pagination" style="float:left"> page <span id="current_page_index">1</span> / <span id="last_page_index"></span></div>
            	<div id="next_page" style="display:none;">|&nbsp;<a href="javascript:void(0)" onclick="abOBJ.convert('Next Page');trascriptNextSlice(1)">Next »</a></div>
            </div>
            <div class="cleaner"></div>
          </div>
            <div id="related_promo_container_rel" class="rta_bottom" style="display:none">
  <span class="title_wrap">
    <div class="rta_bottom_title" id="related_promo_title">This transcript was sent to <span id="promo_num_of_rta_rel">626</span> people who get email alerts on <span class="replace_by_rel_slug">&nbsp;</span>.</div>
  </span>
  <div class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('rel')">Get email alerts on <span class="replace_by_rel_slug">&nbsp;</span><span class='rta_bottom_arrow'> &raquo;</span></div>
  <div class="m_pop point_left" id="promotion_box_rel" style="display:none;"></div>
</div>
<div id="related_promo_container_no_rel" class="rta_bottom newsletter" style="display:none">
  <div class="rta_bottom_title">
    This transcript was sent to <span id="dash_newsl_subscr_count_ph">&nbsp;</span> people who get the  newsletter.
    <span class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('no_rel', null)">Get the  newsletter &raquo;</span>
    <span id="promo_no_rel_loader" style="display:none;"><img height="16" width="16" src="http://static3.cdn-seekingalpha.com/images/loader.gif" /></span>
  </div>
  <div class="m_pop" id="promotion_box_no_rel" style="display:none;"></div>
</div>

          
          <script>OpenTranscriptPage("");</script>
          <div id="content_follow_up" class="transcript_follow_up">
            <div id="paging" class="transcript-paging"></div>
            <div id="article_bottom_about" class="article_bottom_units"></div>

            <div class="share_this_page_article_bottom">
              <ul id="page_toolbar" class="page_toolbar">
  <li class="share_this_page_article_toolbar">
    <div class="share_this_page_snippet">
  <div id="first_line_info" style="width:490px">
    <div class="left"><h6><span id="share_slogan" class="fs16">Share this transcript with a colleague</span></h6></div>
  </div>
  <div class="widgets">
    <!-- Email -->

      <span class="email_this" onclick="email_story_to_friends('Article',2183003,'http://seekingalpha.com/article/2183003-senomyxs-ceo-discusses-q1-2014-results-earnings-call-transcript')">
        <div class="email_button"></div>
        <div class="email_bubble">
          <span id="widget_email_count"></span>
          <span class="cor_right"></span>
        </div>
      </span>
    <!-- twitter -->
    <span class="twitter_small">
        <a href="https://twitter.com/share" class="twitter-share-button twitter_share" data-text="Senomyx&#x27;s CEO Discusses Q1 2014 Results - Earnings Call Transcript http://seekingalpha.com/article/2183003-senomyxs-ceo-discusses-q1-2014-results-earnings-call-transcript?source=tweet $SNMX" data-related="salphatrending" data-url=" " data-counturl="http://seekingalpha.com/article/2183003-senomyxs-ceo-discusses-q1-2014-results-earnings-call-transcript" data-count="horizontal">Tweet</a>
    </span>
    <!-- Linked In -->
      <span id="linkedin_1" class="linkedin_small linkedin_share"><script type="IN/Share" data-counter="right" data-onsuccess="linkedin_callback" data-url="http://seekingalpha.com/article/2183003-senomyxs-ceo-discusses-q1-2014-results-earnings-call-transcript?source=linkedin_share"></script></span>
    <!-- facebook -->
    <span id="span_fb_widget_like" class="facebook_small facebook_share"><div class="fb-like" data-href="http://seekingalpha.com/article/2183003-senomyxs-ceo-discusses-q1-2014-results-earnings-call-transcript?source=facebook" data-send="false" data-layout="button_count" data-show-faces="false" data-font="tahoma"></div></span>
    <div id="span_fb_widget_share" style="display: none;margin:0 10px 0 0;" class="fb-like fl" data-href="http://seekingalpha.com/article/2183003-senomyxs-ceo-discusses-q1-2014-results-earnings-call-transcript?source=facebook" data-layout="button" data-action="like" data-show-faces="false" data-share="false"></div>
    <!-- Plusone  -->
      <span id="pluszone" class="plusone_wrap"><span class="plusone plusone_share"><div class="g-plusone" data-size="medium" annotation="bubble" data-width="65" data-callback="plusone_callback"></div></span></span>
    <!-- print -->
      <span class="print_this" onclick="print_article('with_comments')"><Print><div class="print_button"></div></span>
  </div>
</div>

  <script>
     //FB Share button test
     $('span_fb_widget_like').hide();
     $('span_fb_widget_share').show();
     setTimeout(function(){$('span_fb_widget_share').style.background="none";}, 15000);
     $('pluszone').setStyle({'margin-left':'5px'});


    SeekingAlpha.Initializer.AddAfterLoad(function(){
      new Ajax.Updater({success: 'widget_email_count'}, '/form/ajax_get_email_count', {
        method: 'get',
        parameters: {
          item_name: 'Article',
          article_id: '2183003'
        }
      });
    });

  </script>

  </li>
</ul>
            </div>
            <div class="cleaner"></div>
            <div class="comments_with_more">
              <div id="comments_section">
              </div>
            </div>

            <div class="transcript_center_link">
              <a href="/tag/transcripts" sasource="trans_lb_center">Seeking Alpha's Earnings Center</a>
              -- Broad coverage. Powerful search.<br/>And it's free...
              <span class="gray">Why are you paying for something less good?</span>
            </div>
          </div>
        </div>
    </div>
<div class="article_right_content">    
<div class="search_box_container_isolated">
  <div class="search_box">
    <form id="search_box_sa_search" method="get" class="linktosym comp search" action="/search/" onsubmit="return false;">
      <fieldset>
        <input id="autocomplete_sa_search" class="input_text text" type="text" value="search by symbol, author, keyword..." size="25" autocomplete="off" onblur="if($$('.search_box'))$$('.search_box')[0].style.background='';this.style.color=this.value=='' ? '#8D8D8D' : '#000000';handleInput(this,'blur')" onfocus="if($$('.search_box'))$$('.search_box')[0].style.background='#fff';this.style.color='#000000';handleInput(this,'focus')" afteruploadvalue='eFind quotes, people, expressions, transcripts' title='search by symbol, author, keyword...' class="find_transcripts" />
        <input type="button" class="search_button" value="" onclick="if ($('autocomplete_sa_search').value!=$('autocomplete_sa_search').title) AutoCompleteSAConfig.Packages.search.Find()" />
      </fieldset>
      <input type="hidden" name="source" value="search_general" />
      <input type="hidden" id="autocomplete_sa_hidden_search" name="q" value="" />
      <input type="hidden" name="cx" value="018269914407235029540:cdhc2yeo2ko" />
      <input type="hidden" name="cof" value="FORID:11;NB:1" />
      <input type="hidden" name="goto_search_tab" value="" />
    </form>
    <script type="text/javascript">SeekingAlpha.Initializer.LogAndRun(function () { AutoCompleteSAConfig.Load('search', { Symbols:true, IframeCover:true, AfterInsert:function () { this.Find(); }, AfterSubmit:function () { this.Find(); }}) });</script>
    <script type="text/javascript" src="http://www.google.com/coop/cse/brand?form=searchbox_018269914407235029540%3Acdhc2yeo2ko&lang=en"></script>
  </div>
</div>

       <script>var page_ad_src = 'http://ad.doubleclick.net/N6001/adj/sek.earnings/reports;sz=300x251;x=x;tile=4;d=earnings;pos=b;t=reports;aid=2183003;d=sectors;t=transcripts;t=us;t=food-wholesale;t=services;t=article;z=1;a=sa-transcripts;cnt=1;cnt=7;cnt=5;cnt=8;cnt=20;cnt=23;pr=snmx;s=snmx;'+dart_my_vocation_and_profiles()+'ord='+ord+'?';</script>

<div id="ads_and_tools" class='transcript_sidebar_tools red_sidebar'>
  <div class="item banner300x600">
    <script>add_js_to_ad_call('http://ad.doubleclick.net/N6001/adj/sek.earnings/reports;sz=300x250,300x600;x=x;tile=2;d=earnings;pos=t;t=reports;aid=2183003;d=sectors;t=transcripts;t=us;t=food-wholesale;t=services;t=article;z=1;a=sa-transcripts;cnt=1;cnt=7;cnt=5;cnt=8;cnt=20;cnt=23;pr=snmx;s=snmx;'+dart_my_vocation_and_profiles()+'ord='+ord+'?');</script>
  </div>
  <div id="alternative_title_container" class="mini_category data_currencies_table" style="display:none">
  <div class="sidebar_title_bk">
    <span class="sidebar_title_text" id="article_alternative_title"></span>			
  </div>
  <div id="symbol_alternative_tags" class="symbol_alternative_tags"></div>
  <div id="alternatives_pirsomet" class="alternatives_pirsomet" style="float:left;width:100%;"></div>
      <script type="text/javascript">
        ssga_always_display("transcript_120x30", "http://9nl.it/i3eb/");
      </script>
  <div class="cleaner"></div>
</div>

<script type="text/javascript">
  symbol = "SNMX";
  new Ajax.Request('/articles/get_ajax_alternatives_by_symbol?symbol='+symbol, {
    asynchronous:true,
    evalScripts:true,
    method:'get',
    onComplete: function(transport) {
      if (transport.status == 200 && transport.responseText != 'failed') {
        response = transport.responseText.split("@@");
        symbolZiignight = new Ziignight('', 'SAlternative',"","symbolZiignight","symbol_alternative_tags","ETF");
        symbolZiignight.WorkJSON = eval(response[1]);
        symbolZiignight.addETF = false;
        symbolZiignight.pageType = 'Article';
        symbolZiignight.selectedSymbol = symbol;
        symbolZiignight.SAlternativePrint(-1,true);
        symbolZiignight.InsertEtfAlternativeSymbol(response[0]);
        $('article_alternative_title').innerHTML = response[0].toUpperCase() + " vs. ETF alternatives";
        $("alternative_title_container").style.display = "";
      }
    }
  });
</script>


  <div id="block_find_in_transcript">    
    <div class="search_quote_transcripts">
      <div class="mini_category">
        <div class="sidebar_title_bk">
          <span class="sidebar_title_text">Search  transcript</span>
        </div>
        <form id="search_transcript_form_in_this" onsubmit="return false;">
          <span style="float:left;margin-top:7px;margin-right:10px;">This Transcript</span>
          <input type="hidden" value="-1" name="page" />
          <span id="search_box_text_field_span_in_this" class="shine_search_off">
            <input type="text" class="text" name="term" id="search_transcript_in_this" value='e.g. "this quarter"' title='e.g. "this quarter"' afterUploadValue='e.g. "this quarter"' onfocus="this.style.color='#000000';handleInput(this,'focus');" onblur="this.style.color=this.value=='' ? '#BCBCBC' : '#000000';handleInput(this,'blur');" autocomplete="off" onkeypress="if (event.keyCode==13) { find_in_relevant_search_in_this(); }" />
          </span>
          <input type="button" value="Find" class="submit" id="submit_search_transcript_in_this" onclick="find_in_relevant_search_in_this();" />
          <div id="word_not_found_message_in_this" class="word_not_found_message" style="display:none;">Text not found.</div>
        </form>
        <form id="search_transcript_form_in_all" onsubmit="return false;">
          <span style="float:left;margin-top:7px;margin-right:12px;">All Transcripts</span>
          <input type="hidden" value="-1" name="page" />
          <span id="search_box_text_field_span_in_all" class="shine_search_off">
            <input type="text" class="text" name="term" id="search_transcript_in_all" value='e.g. "this quarter"' title='e.g. "this quarter"' afterUploadValue='e.g. "this quarter"' onfocus="this.style.color='#000000';handleInput(this,'focus');" onblur="this.style.color=this.value=='' ? '#BCBCBC' : '#000000';handleInput(this,'blur');" autocomplete="off" onkeypress="if (event.keyCode==13) { find_in_relevant_search_in_all(); }" />
          </span>
          <input type="button" value="Find" class="submit" id="submit_search_transcript_in_all" onclick="find_in_relevant_search_in_all();" />
          <div id="word_not_found_message_in_all" class="word_not_found_message" style="display:none;">Text not found.</div>
        </form>
      </div>
      <div class="cleaner"></div>
    </div>
  </div>
  <br>
    <div class="mini_category">
    <div class="compare_to_snippet">
      <div class="sidebar_title_bk">
        <span class="sidebar_title_text">Compare to:</span>
      </div>
      <div class="compare_to_snippet_content">
        <div id="article_transcript_previous_statement_sidebar">
          <ul>
            <li><a href="/symbol/snmx/transcripts">All SNMX Transcripts</a></li>
            <li><a href="/analysis/transcripts/services">Other Companies in this sector</a></li>
        </ul>			
      </div>
    </div>
  </div>
  </div>

   <div id="earning_survey" class="mini_category" style="width:300px; height: 250px;display:none">
    <div class="compare_to_snippet">
      <div class="sidebar_title_bk">
        <span class="sidebar_title_text">EARNINGS CALL FEEDBACK SURVEY</span>
      </div>
      <div id="earning_survey_container">
        <div><b>Senomyx, Inc.</b> released its FQ4 2013 Results in their Earnings Call on May 01, 2014.</div>
        <div id="earning_survey_question" class="mt10">Do you feel more positive or less positive about <b>Senomyx, Inc.</b> after ready these results?</div>
        <div id="earning_survey_answer">
            <input class="mt10" type="radio" name="morePositive" onclick="nextQuestion(true, this.value)" value="More Positive">More Positive<br>
            <input class="mt10" type="radio" name="lessPositive" onclick="nextQuestion(false, this.value)" value="Less Positive">Less Positive<br>
            </div>
    </div>
      <div id="earnings_survey_email_checkbox" style="display: none" class="mt10"><input id="checkbox_receive_earnings_result" type="checkbox" name="vehicle">I would like to receive survey results<br></div>
    </div>
 </div>

<script>
var receiveResults = 'no';
var questionNumber = 1;
var symbolName = 'Senomyx, Inc.';
var container = $('earning_survey_container');
Mone.event('tr_survey','first_q','shown');

function getTextBoxContent(){
  return $("earning_survey_comment").value;
}

function nextQuestion(positiveAnswer, answerContent){
  questionNumber++;
  if($('checkbox_receive_earnings_result').checked){
    receiveResults = 'yes';
  }
    switch(questionNumber){
    case 2:
      if(positiveAnswer){
        firstAnswerWasPositive = true;
        Mone.event('tr_survey','first_q','more_positive',{data:{send_results:receiveResults}});
        transition('<div id="earning_survey_question">Do you currently own <b>' + symbolName + '</b> Company stock?</div>\n\
         <div id="earning_survey_answer"><form action=""><input class="mt10" type="radio" name="yes" onclick="nextQuestion(true, this.value)" value="Yes">Yes<br>\n\
        <input class="mt10" type="radio" name="no" onclick="nextQuestion(false, this.value)" value="No">No</form> </div>');
        Mone.event('tr_survey','second_q_more','shown');
      }
      else{
        firstAnswerWasPositive = false;
        Mone.event('tr_survey','first_q','less_positive',{data:{send_results:receiveResults}});
        transition('<div id="earning_survey_question"> What would help you feel more positive about <b>' + symbolName + '</b> Company as an investment opportunity?</div>\n\
               <textarea id="earning_survey_comment" rows="4" cols="38" placeholder="Write here your comment"></textarea>\n\
                <a href="javascript:nextQuestion(false, getTextBoxContent());"><div id="eaning_survey_submit">Submit &raquo;</div></a>');
        Mone.event('tr_survey','second_q_less','shown');
        
      }
      break;

    case 3:
      if(firstAnswerWasPositive){
        if(positiveAnswer){
          Mone.event('tr_survey','second_q_more','yes', {data:{send_results:receiveResults}});
        } 
        else{
          Mone.event('tr_survey','second_q_more','no', {data:{send_results:receiveResults}});
        }
        transition('<div id="earning_survey_question">Are you more or less likely to purchase <b>'+ symbolName + '</b> as a result of reading this transcript?</div>\n\
          <center><form action=""><input class="mt10" type="radio" name="moreLikely" onclick="nextQuestion(true, this.value)" value="More likely to purchase stock">More likely to purchase stock<br>\n\
          <input class="mt10" type="radio" name="lessLikely" onclick="nextQuestion(false, this.value)" value="Less likely to purchase stock">Less likely to purchase stock</form></center>');
          Mone.event('tr_survey','third_q','shown');
        }
      else{
        Mone.event('tr_survey','second_q_less','submited',{data:{answer:answerContent, send_results:receiveResults}});
        thanksMessage();
      }
      break;
      
    case 4:
      if(positiveAnswer)
        Mone.event('tr_survey','third_q','more_likely', {data:{send_results:receiveResults}});
      else
        Mone.event('tr_survey','third_q','less_likely', {data:{send_results:receiveResults}});
      
      thanksMessage();
      break;
  }
  function thanksMessage(){
    transition('<div id="earning_survey_question"></div><div id="earning_survey_comment">Thank you for your response.</div>', true);
  }
}

function transition(newHTML, isTanksMessage){
  Effect.Fade($('earnings_survey_email_checkbox'));
  Effect.Fade(container, { afterFinish:
                  function () {
                    container.update(newHTML);
                    container.appear();
                    if(receiveResults == 'no' && !isTanksMessage && SA.Data.User.email()) $('earnings_survey_email_checkbox').appear();
                    else $('earnings_survey_email_checkbox').fade();
                   // else $('earnings_survey_email_checkbox').appear();

          } } );

}

</script>
  <div class="stickyad_wrapper">
    <div class="item banner300x250" id="transcript_dart_sticky"></div>
  </div>
  <script type="text/javascript">
     SA.Utils.Ads.add({el:$('transcript_dart_sticky'), HadCreated:false, size:'300x250', delta:10, info:'http://ad.doubleclick.net/N6001/adj/sek.earnings/reports;sz=300x251;x=x;tile=4;d=earnings;pos=b;t=reports;aid=2183003;d=sectors;t=transcripts;t=us;t=food-wholesale;t=services;t=article;z=1;a=sa-transcripts;cnt=1;cnt=7;cnt=5;cnt=8;cnt=20;cnt=23;pr=snmx;s=snmx;'+dart_my_vocation_and_profiles()+'ord='+ord+'?'});
     SA.Utils.Ads.run();
  </script>

</div>

<script>
  function find_in_relevant_search_in_this() {
    if ($('search_transcript_in_this').value.trim() == "" || $('search_transcript_in_this').value == 'e.g. "this quarter"') return false;
    ValidFindInTranscript();    
  }
  function find_in_relevant_search_in_all() {
    if ($('search_transcript_in_all').value.trim() == "" || $('search_transcript_in_all').value == 'e.g. "this quarter"') return false;
    FindTermInAllTranscripts($('search_transcript_form_in_all'), 'transcript_page');
  }
</script>
</div>
  
  </div>
  <input id="short_url" type="hidden" value="http://seekingalpha.com/a/1asez" />
</div>
<div id='footer_break'><div></div></div><div id="footer">
  <div id="footernav">
    <div class="footernav_left">
      <a href="http://seekingalpha.com" class="footernav_logo"></a>
      <div class="footernav_boards">
        <div><span class="footer_title">TOP AUTHORS:</span>&nbsp;<a class="top_authors" href="http://seekingalpha.com/leader-board/opinion-leaders">The Opinion Leaders</a></div>
        <div class='top_boards'>
          <span class="footer_title">TOP USERS:</span>
          <a href="http://seekingalpha.com/leader-board/top-stocktalkers">StockTalkers</a> <span class="fl_dash">|</span>
          <a href="http://seekingalpha.com/leader-board/top-instablogs">Instablogs</a>
        </div>    
      </div>
      <div class="cleaner"></div>
    </div>
    
     <div class="footernav_share_buttons">
   <a href="https://www.facebook.com/Seekingalpha" class="share_btn fb" sasource="footer" target="_blank"></a>
   <a href="https://twitter.com/SAlphaTrending" class="share_btn twitter" sasource="footer" target="_blank"></a>
   <a href="https://plus.google.com/+seekingalpha" class="share_btn google" rel="publisher" sasource="footer" target="_blank"></a>
    </div>
    <div class="footernav_right">
      <div class="footernav_links">
        <a href="http://seekingalpha.com/apps" sasource="footer">Mobile Apps</a>&nbsp;&nbsp;|&nbsp;
        <a class="small_rss" href="http://seekingalpha.com/page/feeds" sasource="footer">&nbsp;&nbsp;&nbsp;&nbsp;RSS Feeds</a>&nbsp;&nbsp;|&nbsp;
        <a href="http://seekingalpha.com/sitemap" sasource="footer">Sitemap</a>&nbsp;&nbsp;|&nbsp;
        <a href="http://seekingalpha.com/page/about_us" sasource="footer">About Us</a>&nbsp;&nbsp;|&nbsp;
        <a href="http://seekingalpha.com/page/contact" sasource="footer">Contact Us</a>
      </div>
      <div class="footernav_more_links">
        <a href="http://seekingalpha.com/page/terms-of-use" sasource="footer">Terms of Use</a> |
        <a href="http://seekingalpha.com/page/privacy" sasource="footer">Privacy</a> |
        <a href="http://www.xignite.com" rel="nofollow" target="_blank">Xignite quote data</a> |
        <span>&#169; 2014 Seeking Alpha</span>
      </div>
      <div class="cleaner"></div>
    </div>
  </div>
  <div class="cleaner"></div>
</div>
<script>
  if (SA.Data.User.loggedIn() && is_pro) {
    setProDashboardUrl($$('a[href="/dashboard/pro"]'));
  }
</script>
<div id="first_portfolio_unit_ref" style="display: none"> <div>
  <table id="first_portfolio_unit" style="border-top: 1px solid #DDD; padding-bottom: 7px !important; padding-top: 4px;">
    <thead><tr><th class="fs12">Symbol</th><th class="tr fs12">Price</th><th class="tr fs12">% Chg</th><th></th><th class="tc fs12">Remove</th><th></th></thead>
    <tbody>
         <tr id="first_portfolio_unit_cell0" class="mb10">
        <td style="width: 25%"><input id="first_portfolio_symbol_input0" class="fpu_input" placeholder="Type Ticker" maxlength="9"></td>
        <td style="width: 22%" id="first_portfolio_unit_symbol_price0" class="tr fs12">-</td>
        <td style="width: 20%" id="first_portfolio_unit_symbol_price_change0" class="tr fs12">-</td>
        <td style="width: 13%">&nbsp;</td>
        <td style="width: 7%" ><span id="first_portfolio_unit_symbol_price_remove_button0" class="remove_btn" onclick="SA.Units.Portfolio.First_portfolio_unit.removeSymbol('first_portfolio_unit_cell0')"></span></td>
        <td style="width: 13%">&nbsp;</td>
        </tr>
        <tr id="first_portfolio_unit_cell1" class="mb10 b-light-gray2">
        <td style="width: 25%"><input id="first_portfolio_symbol_input1" class="fpu_input" placeholder="Type Ticker" maxlength="9"></td>
        <td style="width: 22%" id="first_portfolio_unit_symbol_price1" class="tr fs12">-</td>
        <td style="width: 20%" id="first_portfolio_unit_symbol_price_change1" class="tr fs12">-</td>
        <td style="width: 13%">&nbsp;</td>
        <td style="width: 7%" ><span id="first_portfolio_unit_symbol_price_remove_button1" class="remove_btn" onclick="SA.Units.Portfolio.First_portfolio_unit.removeSymbol('first_portfolio_unit_cell1')"></span></td>
        <td style="width: 13%">&nbsp;</td>
        </tr>
         <tr id="first_portfolio_unit_cell2" class="mb10">
        <td style="width: 25%"><input id="first_portfolio_symbol_input2" class="fpu_input" placeholder="Type Ticker" maxlength="9"></td>
        <td style="width: 22%" id="first_portfolio_unit_symbol_price2" class="tr fs12">-</td>
        <td style="width: 20%" id="first_portfolio_unit_symbol_price_change2" class="tr fs12">-</td>
        <td style="width: 13%">&nbsp;</td>
        <td style="width: 7%" ><span id="first_portfolio_unit_symbol_price_remove_button2" class="remove_btn" onclick="SA.Units.Portfolio.First_portfolio_unit.removeSymbol('first_portfolio_unit_cell2')"></span></td>
        <td style="width: 13%">&nbsp;</td>
        </tr>
        <tr id="first_portfolio_unit_cell3" class="mb10 b-light-gray2">
        <td style="width: 25%"><input id="first_portfolio_symbol_input3" class="fpu_input" placeholder="Type Ticker" maxlength="9"></td>
        <td style="width: 22%" id="first_portfolio_unit_symbol_price3" class="tr fs12">-</td>
        <td style="width: 20%" id="first_portfolio_unit_symbol_price_change3" class="tr fs12">-</td>
        <td style="width: 13%">&nbsp;</td>
        <td style="width: 7%" ><span id="first_portfolio_unit_symbol_price_remove_button3" class="remove_btn" onclick="SA.Units.Portfolio.First_portfolio_unit.removeSymbol('first_portfolio_unit_cell3')"></span></td>
        <td style="width: 13%">&nbsp;</td>
        </tr>
         <tr id="first_portfolio_unit_cell4" class="mb10">
        <td style="width: 25%"><input id="first_portfolio_symbol_input4" class="fpu_input" placeholder="Type Ticker" maxlength="9"></td>
        <td style="width: 22%" id="first_portfolio_unit_symbol_price4" class="tr fs12">-</td>
        <td style="width: 20%" id="first_portfolio_unit_symbol_price_change4" class="tr fs12">-</td>
        <td style="width: 13%">&nbsp;</td>
        <td style="width: 7%" ><span id="first_portfolio_unit_symbol_price_remove_button4" class="remove_btn" onclick="SA.Units.Portfolio.First_portfolio_unit.removeSymbol('first_portfolio_unit_cell4')"></span></td>
        <td style="width: 13%">&nbsp;</td>
        </tr>
        <tr id="first_portfolio_unit_cell5" class="mb10 b-light-gray2">
        <td style="width: 25%"><input id="first_portfolio_symbol_input5" class="fpu_input" placeholder="Type Ticker" maxlength="9"></td>
        <td style="width: 22%" id="first_portfolio_unit_symbol_price5" class="tr fs12">-</td>
        <td style="width: 20%" id="first_portfolio_unit_symbol_price_change5" class="tr fs12">-</td>
        <td style="width: 13%">&nbsp;</td>
        <td style="width: 7%" ><span id="first_portfolio_unit_symbol_price_remove_button5" class="remove_btn" onclick="SA.Units.Portfolio.First_portfolio_unit.removeSymbol('first_portfolio_unit_cell5')"></span></td>
        <td style="width: 13%">&nbsp;</td>
        </tr>
         <tr id="first_portfolio_unit_cell6" class="mb10">
        <td style="width: 25%"><input id="first_portfolio_symbol_input6" class="fpu_input" placeholder="Type Ticker" maxlength="9"></td>
        <td style="width: 22%" id="first_portfolio_unit_symbol_price6" class="tr fs12">-</td>
        <td style="width: 20%" id="first_portfolio_unit_symbol_price_change6" class="tr fs12">-</td>
        <td style="width: 13%">&nbsp;</td>
        <td style="width: 7%" ><span id="first_portfolio_unit_symbol_price_remove_button6" class="remove_btn" onclick="SA.Units.Portfolio.First_portfolio_unit.removeSymbol('first_portfolio_unit_cell6')"></span></td>
        <td style="width: 13%">&nbsp;</td>
        </tr>
        <tr id="first_portfolio_unit_cell7" class="mb10 b-light-gray2">
        <td style="width: 25%"><input id="first_portfolio_symbol_input7" class="fpu_input" placeholder="Type Ticker" maxlength="9"></td>
        <td style="width: 22%" id="first_portfolio_unit_symbol_price7" class="tr fs12">-</td>
        <td style="width: 20%" id="first_portfolio_unit_symbol_price_change7" class="tr fs12">-</td>
        <td style="width: 13%">&nbsp;</td>
        <td style="width: 7%" ><span id="first_portfolio_unit_symbol_price_remove_button7" class="remove_btn" onclick="SA.Units.Portfolio.First_portfolio_unit.removeSymbol('first_portfolio_unit_cell7')"></span></td>
        <td style="width: 13%">&nbsp;</td>
        </tr>
         <tr id="first_portfolio_unit_cell8" class="mb10">
        <td style="width: 25%"><input id="first_portfolio_symbol_input8" class="fpu_input" placeholder="Type Ticker" maxlength="9"></td>
        <td style="width: 22%" id="first_portfolio_unit_symbol_price8" class="tr fs12">-</td>
        <td style="width: 20%" id="first_portfolio_unit_symbol_price_change8" class="tr fs12">-</td>
        <td style="width: 13%">&nbsp;</td>
        <td style="width: 7%" ><span id="first_portfolio_unit_symbol_price_remove_button8" class="remove_btn" onclick="SA.Units.Portfolio.First_portfolio_unit.removeSymbol('first_portfolio_unit_cell8')"></span></td>
        <td style="width: 13%">&nbsp;</td>
        </tr>
        <tr id="first_portfolio_unit_cell9" class="mb10 b-light-gray2">
        <td style="width: 25%"><input id="first_portfolio_symbol_input9" class="fpu_input" placeholder="Type Ticker" maxlength="9"></td>
        <td style="width: 22%" id="first_portfolio_unit_symbol_price9" class="tr fs12">-</td>
        <td style="width: 20%" id="first_portfolio_unit_symbol_price_change9" class="tr fs12">-</td>
        <td style="width: 13%">&nbsp;</td>
        <td style="width: 7%" ><span id="first_portfolio_unit_symbol_price_remove_button9" class="remove_btn" onclick="SA.Units.Portfolio.First_portfolio_unit.removeSymbol('first_portfolio_unit_cell9')"></span></td>
        <td style="width: 13%">&nbsp;</td>
        </tr>
    </tbody>
  </table>
</div>
<script>SA.Units.Portfolio.First_portfolio_unit.init('first_portfolio_symbol_input',10, 'transcript Register')</script>
</div>

<script type="text/javascript">
  Event.observe(window, 'scroll', run_article_end_mone);
  if (location.href.match(/part=single/) == null){
  	$('tab_cmd').show();
  	$('pag_cmd').show();
  }

  if (!rb_yahoo_promo()) {
    $('last_page_index').innerHTML = getPartialSlice(1,sliceSize,false,true,true);
  }

  /* Roadblock test */
  function transcript_rb_show(){
     if (readCookie('user_email') && readCookie('user_email').length > 0 && !AlphaBox.isOpen) {
       SA.Utils.Popup.roadblock_login(); return;
     }
     if (SA.Utils.Env.isIPad){
         ipad_roadblock_new();

     }  else {
       title = "Seeking Alpha transcribes 10,000+ earnings calls per year. For full, free access to these transcripts, please register and set up a portfolio in two easy steps:";
       new RoadblockPopup('Roadblock', 'transcript').roadblock_articles();
     }
  }
  /* Roadblock test */

  SeekingAlpha.Initializer.onDOMLoad(function(){ 
    SA.Pages.Article.init();
    if ($('article_source')) {$('article_source').hide();}
    /* Roadblock test */

    SA.Pages.Article.primary = "snmx";
    rb = new roadblock('transcript');
    rb.additional_login_title = " for full transcript access";
    rb.register_show = transcript_rb_show;
    if (readCookie('ivebeenhere') && !readCookie("sessioncfr")) {
      if (!SA.Data.User.loggedIn() && !SA.Pages.Article.from_partner() && location.href.match("page=([0-9]+)") && location.href.match("page=([0-9]+)")[1] > 1) {
        new RoadblockPopup('Roadblock', 'transcript').roadblock_articles();
      }
    } else {
        createCookie('ivebeenhere',true);
    }
    if (!SA.Data.User.loggedIn()){
      SA.Pages.Article.hide_features_for_roadblock();
      if ($('tab_single_bottom')) {$('tab_single_bottom').show();}
    }
    /* Roadblock test */
  });
  
    SeekingAlpha.Initializer.AddAfterLoad(function(){
      if (!rb_yahoo_promo()) {SA.Pages.Article.articlePromo({"allSlugs":["snmx"],"primarySlug":"snmx"});}
    });
</script>
    <script src="http://static1.cdn-seekingalpha.com/javascripts/packaged/jspell_packaged.js?1398841689" type="text/javascript"></script>
<link href="http://static3.cdn-seekingalpha.com/stylesheets/packaged/footer_packaged.css?1398841707" media="screen" rel="stylesheet" type="text/css" /><script type="text/javascript">
  if(typeof (authors) == "undefined" || typeof (symbols) == "undefined")
    load_remote_script("http://static.cdn-seekingalpha.com/javascripts/packaged/sa.js");
  if(is_users_cookie_exists() && !cookieExists('tops') && typeof(tops) == "undefined")
    load_remote_script("http://static.cdn-seekingalpha.com/javascripts/tops.js?1396435233");
  Mone.renderedParams = {};
  SeekingAlpha.Initializer.AddAfterLoad(function(){SA.Performance.Utils.loadPrintStyle('http://static1.cdn-seekingalpha.com/stylesheets/print.css?t=1398947911')});

  if (SA && SA.Data && SA.Data.User && SA.Data.User.loggedIn() && SA.Data.User.email() && SA.Data.User.email().match(/@seekingalpha.com/)){
    try{$('user_settings_pop').children[0].insert("<li class='mt10'><a href='javascript:void(0)' onclick='switch_status()'>PRO ON / OFF</a></li>");}catch(e){}
  }

  function switch_status(){
    new Ajax.Request('/authentication/get_menu', {
      asynchronous:true,
      method:'get',
      onComplete: function(transport) {
        eval(transport.responseJSON.code);
      }
    });
  }

  try{
    if (!siteon) {
      $('header').outerHTML += '<div id="outage_message">Most of Seeking Alpha is currently unavailable due to scheduled maintenance. Most published articles are still available for viewing. We apologize for any inconvenience.</div>';
      $('user_settings_wrapper').hide();
      $('outage_message').style.top = document.viewport.getDimensions().height -48 + "px";
    }
  } catch(e){}
</script>
<noscript>
  <img src="http://b.scorecardresearch.com/p?c1=2&c2=8500672&cv=2.0&cj=1" width="0" height="0" />
</noscript>
<script src="http://static2.cdn-seekingalpha.com/javascripts/packaged/footer_packaged.js?1398929816" type="text/javascript"></script><div id="symbol_data_script_container"></div>
<script type="text/javascript">
SeekingAlpha.Initializer.onDOMLoad(function(){
  if(SA.Pages && SA.Pages.Account && SA.Pages.Account.Portfolios){
    var a = SA.Pages.Account.Portfolios.alertsTab;
    SA.Pages.Account.Portfolios.alertsTab = function(b){if ($('ziignight_submit')) a(b);}
  }
});
if (/\/account\/portfolio/.test(location.href)) {document.getElementsByTagName("html")[0].style.overflow = "auto"};
if (!$("comment_form_wrapper") && /seekingalpha\.com\/currents\/post/.test(location.href) && $("ads_and_tools")){ $("ads_and_tools").style.position = 'absolute';$("ads_and_tools").style.top="60px";$("ads_and_tools").style.right="0";};
</script>
<style>
.portfolio_news #content_wrapper .left_content .market_currents ul#mc_news li  .bullet{* position: static;* padding:0 6px 6px 1px;}
</style>



<div style="display: none">
  <script>
    /* <![CDATA[ */
    var google_conversion_id = 976471699;
    var google_conversion_label = "yEDNCN3OkAoQk43P0QM";
    var google_custom_params = window.google_tag_params; //defined in google_conversion.js, footer package
    var google_remarketing_only = true;
    /* ]]> */
  </script>
  <script type="text/javascript" src="//www.googleadservices.com/pagead/conversion.js"></script>
</div>
    <div class="cleaner"></div>
  </body>
</html>
